Monday, May 1, 2017

Vol. 23, No. 9

TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 23, No. 9  May 1, 2017
(The next issue will be on May 15, 2017)
_________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
_________________________________
PAPERS IN PRESS
None submitted for this issue.
_________________________________
UPCOMING MEETINGS EVENTS
General info on upcoming meetings of interest:
http://tf7.org/meetings.htm

ISTH also maintains a list of upcoming meetings of interest:
_________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
https://www.ncbi.nlm.nih.gov/sites/myncbi/james.morrissey.1/collections/52521147/public/

Broussard J, Berlinger M, Lauret D (2017) A Clot (Possibly); Due to Loss of TNF-alpha Supression. J La State Med Soc 169:52.
http://www.ncbi.nlm.nih.gov/pubmed/28414674

Chen JJ, Wang AQ, Chen QQ (2017) DNA methylation assay for colorectal carcinoma. Cancer Biol Med 14:42-49.
http://www.ncbi.nlm.nih.gov/pubmed/28443202


Chitlur M, Rajpurkar M, Recht M, Tarantino MD, Yee DL, Cooper DL, Gunawardena S (2017) Recognition and management of platelet-refractory bleeding in patients with Glanzmann's thrombasthenia and other severe platelet function disorders. Int J Gen Med 10:95-99.
http://www.ncbi.nlm.nih.gov/pubmed/28435309


Christersson C, Thulin A, Siegbahn A (2017) Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events. Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/28424820


Cisowska-Czajka ME, Mazij MP, Kotschy MH, Lewczuk J (2016) Plasma concentrations of tissue factor and its inhibitor in chronic thromboembolic pulmonary hypertension: a step closer to explanation of the disease aetiology? Kardiol Pol 74:1332-1338.
http://www.ncbi.nlm.nih.gov/pubmed/27221958


Cosar H, Isik H, Cakir SC, Yar N, Goksen B, Tokbay H, . . . Durak I (2017) Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study. Paediatr Drugs 19:53-58.
http://www.ncbi.nlm.nih.gov/pubmed/27826851


Crispel Y, Ghanem S, Attias J, Kogan I, Brenner B, Nadir Y (2017) Involvement of heparanase procoagulant domain in bleeding and wound healing. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/28439967


da Silva GC, Abbas M, Khemais-Benkhiat S, Burban M, Ribeiro TP, Toti F, . . . Schini-Kerth VB (2017) Replicative senescence promotes prothrombotic responses in endothelial cells: Role of NADPH oxidase- and cyclooxygenase-derived oxidative stress. Exp Gerontol.
http://www.ncbi.nlm.nih.gov/pubmed/28412252


de Souza GR, Hounkpe BW, Fiusa MML, Colella MP, Annichino-Bizzacchi JM, Traina F, . . . De Paula EV (2017) Tissue factor-dependent coagulation activation by heme: A thromboelastometry study. PLoS One 12:e0176505.
http://www.ncbi.nlm.nih.gov/pubmed/28437457


Deng C, Wu S, Zhang L, Yang M, Lin Q, Xie Q, . . . Jin Y (2017) Role of monocyte tissue factor on patients with non-small cell lung cancer. Clin Respir J.
http://www.ncbi.nlm.nih.gov/pubmed/28419722


Dennis J, Medina-Rivera A, Truong V, Antounians L, Zwingerman N, Carrasco G, . . . Gagnon F (2017) Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels. Genet Epidemiol.
http://www.ncbi.nlm.nih.gov/pubmed/28421636


Diamond SL (2016) Systems Analysis of Thrombus Formation. Circ Res 118:1348-1362.
http://www.ncbi.nlm.nih.gov/pubmed/27126646


Ding R, Zhao D, Li X, Liu B, Ma X (2017) Rho-kinase inhibitor treatment prevents pulmonary inflammation and coagulation in lipopolysaccharide-induced lung injury. Thromb Res 150:59-64.
http://www.ncbi.nlm.nih.gov/pubmed/28043040


Forier C, Boschetti E, Ouhammouch M, Cibiel A, Duconge F, Nogre M, . . . Perret G (2017) DNA aptamer affinity ligands for highly selective purification of human plasma-related proteins from multiple sources. J Chromatogr A 1489:39-50.
http://www.ncbi.nlm.nih.gov/pubmed/28179082


Gaitzsch E, Czermak T, Ribeiro A, Heun Y, Bohmer M, Merkle M, . . . Pircher J (2017) Double-stranded DNA induces a prothrombotic phenotype in the vascular endothelium. Sci Rep 7:1112.
http://www.ncbi.nlm.nih.gov/pubmed/28442771


Han X, Zha H, Yang F, Guo B, Zhu B (2017) Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells. Int J Mol Sci 18.
http://www.ncbi.nlm.nih.gov/pubmed/28106852


Hansson KM, Johansson KJ, Wingren C, Fries D, Nelander K, Lovgren A (2017) Recombinant human prothrombin reduced blood loss in a porcine model of dilutional coagulopathy with uncontrolled bleeding. Blood Coagul Fibrinolysis 28:244-253.
http://www.ncbi.nlm.nih.gov/pubmed/27428015


Hisada Y, Auriemma AC, Alexander W, Ay C, Mackman N (2017) Detection of tissue factor-positive extracellular vesicles by laser scanning confocal microscopy. Thromb Res 150:65-72.
http://www.ncbi.nlm.nih.gov/pubmed/28043041


Jahanban-Esfahlan R, Seidi K, Zarghami N (2017) Tumor vascular infarction: prospects and challenges. Int J Hematol 105:244-256.
http://www.ncbi.nlm.nih.gov/pubmed/28044258


Kavakli K, Demartis F, Karimi M, Eshghi P, Neme D, Chambost H, . . . Benson G (2017) Safety and effectiveness of room temperature stable recombinant factor VIIa in patients with haemophilia A or B and inhibitors: Results of a multinational, prospective, observational study. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/28440004


Koizume S, Miyagi Y (2017) Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O(2) and Plasma Supply. Int J Mol Sci 18.
http://www.ncbi.nlm.nih.gov/pubmed/28417928


Lentz SR, Rangarajan S, Karim FA, Andersen PD, Arkhammar P, Rosu G, Mahlangu J (2017) The potential correlation between patient-reported symptoms and the use of additional haemostatic medication for joint bleeding in haemophilia patients with inhibitors: a post hoc exploratory analysis of recombinant activated factor VII data from the ADEPT2 trial. Blood Coagul Fibrinolysis 28:224-229.
http://www.ncbi.nlm.nih.gov/pubmed/27427786


Ogawa Y, Kunishima S, Yanagisawa K, Osaki Y, Uchiyama Y, Matsumoto N, . . . Handa H (2017) Successful management of perioperative hemostasis in a patient with Glanzmann thrombasthenia who underwent a right total mastectomy. Int J Hematol 105:221-225.
http://www.ncbi.nlm.nih.gov/pubmed/27696190


Quintavalle G, Riccardi F, Rivolta GF, Martorana D, Di Perna C, Percesepe A, Tagliaferri A (2017) F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency. Results from a genotype-phenotype study. Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/28447100


Rocino A, Franchini M, Coppola A (2017) Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX. J Clin Med 6.
http://www.ncbi.nlm.nih.gov/pubmed/28420167


Santamaria S, Reglinska-Matveyev N, Gierula M, Camire RM, Crawley JTB, Lane DA, Ahnstrom J (2017) Factor V anticoagulant cofactor activity that targets the early phase of coagulation. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/28420729


Skowerski T, Banska-Kisiel K, Grzywocz P, Skowerski M, Gasior Z (2017) Pulmonary embolism in a patient with mild factor VII deficiency after administration of recombinant activated factor VII during a urological procedure. Pol Arch Intern Med 127:285-286.
http://www.ncbi.nlm.nih.gov/pubmed/28452972


Swier N, Versteeg HH (2017) Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression. Thromb Res 150:8-18.
http://www.ncbi.nlm.nih.gov/pubmed/27988375


Takeda S, Takeda J, Murakami K, Kubo T, Hamada H, Murakami M, . . . Ikeda T (2017) Annual Report of the Perinatology Committee, Japan Society of Obstetrics and Gynecology, 2015: Proposal of urgent measures to reduce maternal deaths. J Obstet Gynaecol Res 43:5-7.
http://www.ncbi.nlm.nih.gov/pubmed/28074548


Tang M, Fenger-Eriksen C, Wierup P, Greisen J, Ingerslev J, Hjortdal V, Sorensen B (2017) Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products. Thromb Res 154:73-79.
http://www.ncbi.nlm.nih.gov/pubmed/28437748


Tischer S, Miller JT (2016) Pharmacologic Strategies to Prevent Blood Loss and Transfusion in Orthotopic Liver Transplantation. Crit Care Nurs Q 39:267-280.
http://www.ncbi.nlm.nih.gov/pubmed/27254642


Tsunaka M, Shinki H, Koyama T (2017) Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia. PLoS One 12:e0175765.
http://www.ncbi.nlm.nih.gov/pubmed/28406995


Wang CY, Chen YC, Lin CH, Hwang KS, Su HY (2016) Successful treatment with recombinant blood factor VIIa in severe postpartum hemorrhage-induced disseminated intravascular coagulation. Taiwan J Obstet Gynecol 55:301-302.
http://www.ncbi.nlm.nih.gov/pubmed/27125421


Wool GD, Chapel D, Treml A, Miller JL (2017) Therapeutic plasma exchange as part of multimodal treatment of acquired hemophilia in a patient with concurrent acute intracerebral bleed and pulmonary embolism. Transfusion.
http://www.ncbi.nlm.nih.gov/pubmed/28436106


Xiao X, Tao X, Wang Y, Zhu L, Ye Y, Liu H, . . . Xiong Y (2017) Hypomethylation of tissue factor pathway inhibitor 2 in human placenta of preeclampsia. Thromb Res 152:7-13.
http://www.ncbi.nlm.nih.gov/pubmed/28208084


Yisireyili M, Hayashi M, Wu H, Uchida Y, Yamamoto K, Kikuchi R, . . . Takeshita K (2017) Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice. Sci Rep 7:1266.
http://www.ncbi.nlm.nih.gov/pubmed/28455534

_________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.

DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
_________________________________

No comments:

Post a Comment